Keyphrases
Movement Disorders
62%
Relapse Rate
50%
Brief Psychiatric Rating Scale
50%
Monotherapy
50%
Psychiatric Symptomatology
50%
Hypokinetic
50%
Long-term Inpatients
50%
Mental Illness
50%
Antipsychotic Polypharmacy
50%
Tardive Dyskinesia
50%
Antipsychotic Monotherapy
50%
Extrapyramidal Syndrome
50%
Dyskinesia
50%
Severe Mental Illness
50%
Curaçao
50%
Second-generation Antipsychotics
50%
Auditory Hallucinations
50%
Autism Spectrum Disorder
50%
Spontaneous Dyskinesia
50%
Instrumental Measurements
50%
Schizotypy
50%
Schizophrenia Symptoms
50%
Healthy Controls
50%
Parkinsonism
50%
Open-label Trial
50%
Motor Disturbances
50%
Related Disorders
50%
Motor Behavior
25%
Psychosis
25%
Force Variability
25%
Mortality Factors
25%
Schizophrenia
25%
Antipsychotics
25%
Adolescents with Autism Spectrum Disorder
25%
Tardive Akathisia
25%
Instrumental Assessment
12%
Instrumental Data
12%
Life Expectancy
12%
Date of Death
12%
Intervention Studies
12%
Observational Scale
12%
Antidepressants
12%
Motor Abnormalities
12%
Clozapine
12%
Benzodiazepines
12%
Logistic Regression Model
12%
Netherlands Antilles
12%
Model Linking
12%
Rating Scales
12%
Childhood Autism
12%
Medicine and Dentistry
Stereotypic Movement Disorder
58%
Recurrence Risk
50%
Symptomatology
50%
Polypharmacy
50%
Open-Label Trial
50%
Dyskinesia
50%
Hallucination
50%
Disease
50%
Extrapyramidal Syndrome
50%
Parkinsonism
50%
Monotherapy
50%
Schizotypy
50%
Brief Psychiatric Rating Scale
40%
Tardive Dyskinesia
40%
Typical Antipsychotic
30%
Akathisia
30%
Severe Mental Illness
30%
Psychosis
18%
Clozapine
10%
Intervention Study
10%
Life Expectancy
10%
Symptom
10%
Population
10%
Rating Scale
10%
Antidepressant
10%
Logistic Regression Analysis
10%
Unified Parkinson's Disease Rating Scale
10%
Proportional Hazards Model
10%
Side Effect
10%
Mortality
10%
Benzodiazepine
10%
Affective Psychosis
8%
Schizotypal Personality Disorder
8%
INIS
patients
100%
motors
57%
spectra
50%
switches
50%
disturbances
50%
mortality
50%
control
50%
psychoses
37%
sex
23%
risks
21%
adjustments
16%
children
16%
data
16%
symptoms
16%
safety
16%
probability
16%
side effects
16%
adolescents
16%
correlations
12%
origin
8%
assessments
8%
comparative evaluations
8%
neural networks
8%
antidepressants
7%
range
7%
nervous system diseases
7%
hypothesis
7%
netherlands antilles
7%
death
7%
populations
7%
design
7%
interventions
7%
